Global Ganja Report

With the end of the legislative session in Albany closing in, odds for legalizing cannabis in New York state this year are fast diminishing. Now a new bill has been introduced, to reconcile rival versions pushed by the Assembly and Gov. Cuomo. It has won support from advocates—but, with the clock ticking, Cuomo equivocates on whether he will support it.

Finally settling a question that has vexed the Arizona medical marijuana program since it was launched nearly a decade ago, the state's highest court ruled that the program does indeed cover concentrates and extracts. The decision is a victory for patients who use edibles, tinctures or hashish.

Colorado's Supreme Court ruled that thanks to the constitutional changes instated by the 2012 cannabis legalization vote, police require probable cause before using drug-sniffing dogs. A dissenting opinion holds that the decision oversteps federal authority, and undermines the jurisprudential basis for Colorado legalization. Are these fears realistic?

Mexico's new populist president announced that he is dropping out of the regional US-led drug enforcement pact, and will be turning down the aid package offered through the program. Instead, he is proposing a dialogue with Washington on across-the-board drug decriminalization in both nations. And Mexican lawmakers say they will pass a cannabis legalization bill by the end of the year.

A group of attorneys general from 38 states and territories penned an open letter urging Capitol Hill to pass a pending bill to allow cannabis businesses access to the federal banking system.

The federal bureaucracy is starting to catch up with the law, following passage of the ground-breaking 2018 Farm Bill. The US Patent Office has issued guidelines for trademarks on CBD products, while the Agriculture Department is preparing to recognize intellectual property in hemp varieties.

Senate Minority Leader Chuck Schumer announced that he will reintroduce his bill to remove cannabis from the federal list of controlled substances—allowing states to set their own laws to regulate the plant without the shadow of Washington interference.

A new report by the British think-tank Prohibition Partners foresees a $5.8 billion cannabis market in Asia by 2024—if the tentative seeds of liberalization now witnessed across the continent in fact bear fruit.